Cargando…

Inhibitor Risk Stratification and Individualized Treatment in Patients With Nonsevere Hemophilia A: A Single-Institution Practice Audit

Inhibitor risk in nonsevere hemophilia A increases with cumulative factor VIII (FVIII) exposure days and high-risk mutations. A standardized approach to minimize inhibitor risk is warranted. Following establishment of a systematic approach to reduce inhibitor risk in nonsevere hemophilia, we evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Haowei (Linda), Chan, Stella, Yenson, Paul, Jackson, Shannon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714690/ https://www.ncbi.nlm.nih.gov/pubmed/29108420 http://dx.doi.org/10.1177/1076029617737836

Ejemplares similares

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Joint status of patients with nonsevere hemophilia A
por: Zwagemaker, Anne‐Fleur, et al.
Publicado: (2022)

Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy
por: Romano, Lorenzo G.R., et al.
Publicado: (2023)

The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A
por: Ay, Cihan, et al.
Publicado: (2023)

Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status
por: Rejtő, Judit, et al.
Publicado: (2023)

Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status
por: Batsuli, Glaivy, et al.
Publicado: (2021)

The impact of extended half‐life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia B
por: Sun, Haowei (Linda), et al.
Publicado: (2021)

Increased blood pressure after nonsevere COVID-19
por: Schmidt-Lauber, Christian, et al.
Publicado: (2023)

Joining the patient on the path to customized prophylaxis: one hemophilia team explores the tools of engagement
por: Gue, Deborah, et al.
Publicado: (2015)

ATYPICAL PRESENTATION OF MUCORMYCOSIS IN A NONSEVERE COVID-19 PATIENT
por: TRAN, STEVEN, et al.
Publicado: (2022)

Product type and the risk of inhibitor development in nonsevere haemophilia A patients: a case‒control study
por: van Velzen, Alice S., et al.
Publicado: (2020)

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A
por: Bachelet, Delphine, et al.
Publicado: (2019)

The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
por: Komagamine, Junpei, et al.
Publicado: (2021)

Molecular Mechanisms of Inhibitor Development in Hemophilia
por: Tieu, Paul, et al.
Publicado: (2020)

Decision Tree Model for Hematology/Oncology Patients with Severe and Nonsevere Sepsis
por: Munger, Jessica A., et al.
Publicado: (2018)

Prognostic nomogram on admission predicting progression for patients with nonsevere COVID-19
por: Wang, Zhi, et al.
Publicado: (2021)

Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of Hemophilia
por: Valizadeh, Leila, et al.
Publicado: (2015)

Femoral Arterial Thrombosis in a Young Adult after Nonsevere COVID-19
por: Veyre, Florian, et al.
Publicado: (2020)

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY
por: Mohabati, Danial, et al.
Publicado: (2020)

Friedman Score in Relation to Compliance and Treatment Response in Nonsevere Obstructive Sleep Apnea
por: Berg, Lars M., et al.
Publicado: (2020)

Development and external validation of a prognostic tool for nonsevere COVID-19 inpatients
por: Luo, Ensi, et al.
Publicado: (2023)

Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents
por: Jackson, Shannon, et al.
Publicado: (2019)

Development and Validation of a Nomogram for Predicting the Disease Progression of Nonsevere Coronavirus Disease 2019
por: Li, Xue-lian, et al.
Publicado: (2021)

Transcatheter Aortic Valve Replacement in Patients With Reduced Ejection Fraction and Nonsevere Aortic Stenosis
por: Ludwig, Sebastian, et al.
Publicado: (2023)

Dynamic risk stratification in medullary thyroid carcinoma: Single institution experiences
por: Choi, Jung Bum, et al.
Publicado: (2018)

Predictors of early progression to severe sepsis or shock among emergency department patients with nonsevere sepsis
por: Holder, Andre L., et al.
Publicado: (2016)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty
por: Shinohara, Masaya, et al.
Publicado: (2019)

Evaluation of oral anticoagulants in atrial fibrillation patients over 80 years of age with nonsevere frailty
por: Noro, Mahito
Publicado: (2019)

Nonsevere Acute Respiratory Syndrome Human Coronaviruses in Children Hospitalized with Acute Lower Respiratory Infection
por: Das, Rashmi Ranjan, et al.
Publicado: (2021)

Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses
por: Bone, Jeffrey N., et al.
Publicado: (2022)

Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
por: Pitre, Tyler, et al.
Publicado: (2022)

In Vitro Assays for Diagnosis of Drug-Induced Nonsevere Exanthemas: A Systematic Review and Meta-Analysis
por: Drygala, Szymon, et al.
Publicado: (2022)

Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis
por: Pengthina, Worachaya, et al.
Publicado: (2022)

Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
por: Sitasuwan, Tullaya, et al.
Publicado: (2022)

Quality of Life in Hemophilia Complicated by Inhibitors
por: Bastani, P, et al.
Publicado: (2012)

Escape or Fight: Inhibitors in Hemophilia A
por: Merlin, Simone, et al.
Publicado: (2020)

A Practical Guide to the Management of the Fetus and Newborn With Hemophilia
por: Moorehead, Paul C., et al.
Publicado: (2018)

Processes of Care Associated With Risk of Mortality and Recurrent Stroke Among Patients With Transient Ischemic Attack and Nonsevere Ischemic Stroke
por: Bravata, Dawn M., et al.
Publicado: (2019)

Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
por: Warren, Beth Boulden, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7lf348bj0j9o3d6u8h35l518d0